2021 ASM-ESCMID Joint Conference Update

Due to the recent surge in COVID-19 cases and the increased community spread of the SARS-CoV-2 Delta variant, the ASM Board of Directors has extended the current no in-person meetings/no travel policy through the end of 2021. As a result, the in-person 2021 ASM-ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, scheduled to take place Sept.21-24, 2021, in Boston, Mass. will move to a virtual format.
At this time, we are working with the Program Committee to plan a virtual conference scheduled for early Dec. 2021. More details will be available in mid-Sept. 2021. 

For additional information, please refer to ASM's COVID-19 resource page and follow ASM’s social media channels (FacebookTwitter and Instagram) for the most up-to-date information about the virus, the disease it causes and any impact on ASM gatherings.